β-cell function: A key pathological determinant in polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 1, 2005, Pages 310-315

  Goodarzi, Mark O ^a,b   Erickson, Stephen ^c   Port, Sidney C ^c   Jennrich, Robert I ^c   Korenman, Stanley G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; INSULIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BIOAVAILABILITY; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HUMAN; HYPERANDROGENISM; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; OBESITY; OVARY POLYCYSTIC DISEASE; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; BIOLOGICAL AVAILABILITY; FEMALE; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; POLYCYSTIC OVARY SYNDROME; REGRESSION ANALYSIS; TESTOSTERONE;

FALLOPIA;

EID: 12244279960     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1006     Document Type: Article

References (49)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R 1998 Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83:3078-3082
3. Dunaif A, Segal KR, Futterweit W, Dobrjansky A 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165-1174
4. Dunaif A 1999 Insulin action in the polycystic ovary syndrome. Endocrinol Metab Clin North Am 28:341-359
5. Carmina E, Lobo RA 1999 Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 84:1897-1899
6. Goodarzi MO, Korenman SG 2003 The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril 80:255-258
7. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A 1987 Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 65:499-507
8. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
9. Vankova M, Vrbikova J, Hill M, Cinek O, Bendlova B 2002 Association of insulin gene VNTR polymorphism with polycystic ovary syndrome. Ann NY Acad Sci 967:558-565
10. Ciampelli M, Fulghesu AM, Cucinelli F, Pavone V, Caruso A, Mancuso S, Lanzone A 1997 Heterogeneity in β-cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 12:1897-1901
11. Ciampelli M, Fulghesu AM, Murgia F, Guido M, Cucinelli F, Apa R, Caruso A, Lanzone A 1998 Acute insulin response to intravenous glucagon in polycystic ovary syndrome. Hum Reprod 13:847-851
12. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SS 1996 Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 81:2854-2864
13. Ke WX, Shan GQ, Hua SY 1996 Different responses of insulin, C-peptide, and testosterone to an oral glucose tolerance test in two groups of women with polycystic ovarian syndrome. Acta Obstet Gynecol Scand 75:166-169
14. Holte J, Bergh T, Beme C, Berglund L, Lithell H 1994 Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance. J Clin Endocrinol Metab 78:1052-1058
15. Tropeano G, Lucisano A, Liberale I, Barini A, Vuolo IP, Martino G, Menini E, Dell'Acqua S 1994 Insulin, C-peptide, androgens, and β-endorphin response to oral glucose in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 78:305-309
16. Holte J, Bergh T, Berne C, Wide L, Lithell H 1995 Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 80:2586-2593
17. Arslanian SA, Lewy VD, Canadian K 2001 Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and β-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 86:66-71
18. Dunaif A, Finegood DT 1996 β-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab 81:942-947
19. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS 1995 Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 96:520-527
20. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GR, eds. Polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific Publications; 377-384
21. Kiningham RB, Apgar BS, Schwenk TL 1996 Evaluation of amenorrhea. Am Fam Physician 53:1185-1194
22. Azziz R, Dewailly D, Owerbach D 1994 Nondassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78:810-815
23. Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG 2003 Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome. Metabolism 52:713-719
24. Wallace TM, Levy JC, Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27:1487-1495
25. Levy JC, Matthews DR, Hermans MP 1998 Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
27. Centers for Disease Control and Prevention 1996 The Third National Health and Nutrition Examination Survey (NHANES III 1988-94) Reference Manuals and Reports [CD-ROM]. Bethesda, MD: National Center for Health Statistics
28. 2 test for the equality of two correlation matrices. J Am Stat Assoc 65:904-912
29. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Charles MA, Bennett PH 1991 A two-step model for development of non-insulin-dependent diabetes. Am J Med 90:229-235
30. O'Meara NM, Blackman JD, Ehrmann DA, Barnes RB, Jaspan JB, Rosenfield RL, Polonsky KS 1993 Defects in β-cell function in functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76:1241-1247
31. Bergman RN, Ader M, Huecking K, Van Citters G 2002 Accurate assessment of β-cell function: the hyperbolic correction. Diabetes 51(Suppl 1):S212-S220
32. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L 2002 Insulin sensitivity and β-cell function in women with polycystic ovary syndrome. Diabetes Care 25:1217-1222
33. Holte J, Gennarelli G, Wide L, Lithell H, Berne C 1998 High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 83:1143-1150
34. Koivunen RM, Juutinen J, Vauhkonen I, Morin-Papunen LC, Ruokonen A, Tapanainen JS 2001 Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes. J Clin Endocrinol Metab 86:2591-2599
35. Colilla S, Cox NJ, Ehrmann DA 2001 Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. J Clin Endocrinol Metab 86:2027-2031
36. Legro RS, Bentley-Lewis R, Driscoll D, Wang SC, Dunaif A 2002 Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity. J Clin Endocrinol Metab 87:2128-2133
37. Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ 1986 Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab 62:904-910
38. Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F 1998 Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83:2001-2005
39. Franks S, Gilling-Smith C, Watson H, Willis D 1999 Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 28:361-378
40. Moghetti P, Castello R, Negri C, Tosi F, Spiazzi GG, Brun E, Balducci R, Toscano V, Muggeo M 1996 Insulin infusion amplifies 17 α- hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81:881-886
41. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410
42. Hanson RL, Pratley RE, Bogardus C, Narayan KM, Roumain JM, Imperatore G, Fagot-Campagna A, Pettitt DJ, Bennett PH, Knowler WC 2000 Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am J Epidemiol 151:190-198
43. Ovesen P, Moller J, Ingerslev HJ, Jorgensen JO, Mengel A, Schmitz O, Alberti KG, Moller N 1993 Normal basal and insulin-stimulated fuel metabolism in lean women with the polycystic ovary syndrome. J Clin Endocrinol Metab 77:1636-1640
44. Chang RJ, Nakamura RM, Judd HL, Kaplan SA 1983 Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359
45. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P 1982 Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med 97:851-855
46. Woodard TL, Burghen GA, Kitabchi AE, Wilimas JA 1981 Glucose intolerance and insulin resistance in aplastic anemia treated with oxymetholone. J Clin Endocrinol Metab 53:905-908
47. Moghetti P, Tosi F, Castello R, Magnani CM, Negri C, Brun E, Furlani L, Caputo M, Muggeo M 1996 The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women. J Clin Endocrinol Metab 81:952-960
48. Peiris AN, Sothmann MS, Aiman EJ, Kissebah AH 1989 The relationship of insulin to sex hormone-binding globulin: role of adiposity. Fertil Steril 52:69-72
49. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM 1995 Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 80:3227-3232